In non hepatic epithelial tumor cell lines, inhibition of EGFR or IGF-1R individually promotes activation of the reciprocal receptor [5] and IGF-2 overexpression has been involved in the resistance of HCC to EGFR inhibition in a rat model [6]. The gene discussed is IGF1R; the disease is hepatocellular carcinoma.